stilbostat: carbamidic deriv of tetrakis(2-chloroethyl)-stilbestrol; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 3037081 |
| MeSH ID | M0053917 |
| Synonym |
|---|
| nsc306903 |
| 991-23-1 |
| nsc-306903 |
| stilbostat |
| [4-[(e)-4-[4-[bis(2-chloroethyl)carbamoyloxy]phenyl]hex-3-en-3-yl]phenyl] n,n-bis(2-chloroethyl)carbamate |
| 15470-58-3 |
| vud64clj7z , |
| unii-vud64clj7z |
| carbamic acid, bis(2-chloroethyl)-, (1,2-diethyl-1,2-ethenediyl)di-4,1-phenylene ester, (e)- |
| stilbestrol n,n,n',n'-tetrakis(2-chloroethyl)dicarbamate |
| 4,4'-stilbenediol, alpha,alpha'-diethyl-, bis[bis(2-chloroethyl)carbamate], (e)- |
| carbamic acid, bis(2-chloroethyl)-, [(1e)-1,2-diethyl-1,2-ethenediyl]di-4,1-phenylene ester |
| DTXSID301046846 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 1 (20.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 4 (80.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||